基础医学与临床 ›› 2018, Vol. 38 ›› Issue (1): 112-117.

• 短篇综述 • 上一篇    下一篇

血液净化治疗多发性骨髓瘤肾脏损害

张磊,陈丽萌   

  1. 北京协和医院
  • 收稿日期:2016-12-12 修回日期:2017-03-22 出版日期:2018-01-05 发布日期:2017-12-26
  • 通讯作者: 陈丽萌 E-mail:chenlpumch@163.com

Application of blood purification in renal impairment of multiple myeloma

  • Received:2016-12-12 Revised:2017-03-22 Online:2018-01-05 Published:2017-12-26

摘要: 肾脏是多发性骨髓瘤常见受累器官,应用血液净化技术快速去除血清中的单克隆游离轻链,是药物治疗的重要补充,主要包括血浆置换和高截留量血液透析。基于随机对照研究的结果,血浆置换能否改善肾脏预后仍存在争议。而高截留量血液透析是近年来快速发展的新型治疗模式,一些前瞻性和回顾性研究均显示出其改善肾脏预后的能力。

关键词: 血浆置换, 高截留量血液透析, 多发性骨髓瘤肾脏损害, 管型肾病, 血清游离轻链

Abstract: Renal impairment is common in multiple myeloma. Besides effective chemotherapy, direct removal of serum free light chain through plasmapheresis or high cut-off hemodialysis is also important in the treatment of renal impairment in multiple myeloma. Based on results of the randomized controlled trials, the role of plasmapheresis in treating renal disease of multiple myeloma is debated. On the other side, high cut-off hemodialysis is novel and recently developed. Many studies have observed its ability to further increase renal response rate when combined with chemotherapy.

Key words: plasmapheresis, high cut-off hemodialysis, renal impairment of multiple myeloma, cast nephropathy, serum free light chain

中图分类号: